ATLANTA, Georgia, Dec. 31 (TNSJou) -- Emory University's Woodruff Health Sciences Center issued the following news release: Emory University is participating in a new Phase 3 vaccine clinical trial for COVID-19. The clinical trial will test the safety and effectiveness of an investigational protein-based vaccine developed by U.S. biotechnology company Novavax, Inc. Emory administered the first doses of the vaccine to volunteers this week at the Ponce de Leon clinical research site at Grady Mem  more

GALLOWAY, New Jersey, Dec. 31 -- Stockton University issued the following news: Maple syrup season has begun at Stockton University. Early in 2020, the university received a $410,000 three-year United States Agriculture Department grant to promote maple sugaring in South Jersey through research and community outreach. This fall, some 20 private property owners in the region are joining Stockton in the project and have begun the process of tapping trees. The Stockton team tapped a few trees o  more

ALBANY, New York, Dec. 31 -- Gov. Andrew Cuomo, D-New York, issued the following news release on Dec. 30: Governor Andrew M. Cuomo today announced completion of the Empire State Trail, now the nation's longest multi-use state trail, which will be fully open on December 31. The trail spans 750-miles total, 75 percent of which is off-road trails ideal for cyclists, hikers, runners, cross-country skiers and snow-shoers. The new recreational trail, which runs from New York City through the Hudson a  more

ALBANY, New York, Dec. 31 -- Gov. Andrew Cuomo, D-New York, issued the following transcript on Dec. 30: Earlier today, Governor Andrew M. Cuomo announced he is signing an Executive Order to extend the requirement that death benefits be paid out to families of frontline government workers for an additional 30 days. The legislation providing these benefits, signed by the Governor in May (Chapter 89 of the Laws of 2020), would otherwise expire on December 31. The Governor also announced that more   more

WASHINGTON, Dec. 31 (TNSJou) -- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases issued the following news release: The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe COVID-19. Investigators   more

BETHESDA, Maryland, Dec. 31 (TNSJou) -- The U.S. Department of Health and Human Services' National Institute of Neurological Disorders and Stroke issued the following news release: In an in-depth study of how COVID-19 affects a patient's brain, National Institutes of Health researchers consistently spotted hallmarks of damage caused by thinning and leaky brain blood vessels in tissue samples from patients who died shortly after contracting the disease. In addition, they saw no signs of SARS-CoV  more